These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2884410)

  • 1. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine.
    Ballou WR; Hoffman SL; Sherwood JA; Hollingdale MR; Neva FA; Hockmeyer WT; Gordon DM; Schneider I; Wirtz RA; Young JF
    Lancet; 1987 Jun; 1(8545):1277-81. PubMed ID: 2884410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine.
    Young JF; Hockmeyer WT; Gross M; Ballou WR; Wirtz RA; Trosper JH; Beaudoin RL; Hollingdale MR; Miller LH; Diggs CL
    Science; 1985 May; 228(4702):958-62. PubMed ID: 2988125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adults.
    Sturchler D; Berger R; Rudin C; Just M; Saul A; Rzepczyk C; Brown G; Anders R; Coppel R; Woodrow G
    Am J Trop Med Hyg; 1995 Oct; 53(4):423-31. PubMed ID: 7485698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum.
    Hoffman SL; Wistar R; Ballou WR; Hollingdale MR; Wirtz RA; Schneider I; Marwoto HA; Hockmeyer WT
    N Engl J Med; 1986 Sep; 315(10):601-6. PubMed ID: 3526148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of human volunteer sera to candidate Plasmodium falciparum circumsporozoite protein vaccines in the inhibition of sporozoite invasion assay of human hepatoma cells and hepatocytes.
    Hollingdale MR; Appiah A; Leland P; do Rosario VE; Mazier D; Pied S; Herrington DA; Chulay JD; Ballou WR; Derks T
    Trans R Soc Trop Med Hyg; 1990; 84(3):325-9. PubMed ID: 2175464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites.
    Egan JE; Hoffman SL; Haynes JD; Sadoff JC; Schneider I; Grau GE; Hollingdale MR; Ballou WR; Gordon DM
    Am J Trop Med Hyg; 1993 Aug; 49(2):166-73. PubMed ID: 8357078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals.
    Herrington D; Davis J; Nardin E; Beier M; Cortese J; Eddy H; Losonsky G; Hollingdale M; Sztein M; Levine M
    Am J Trop Med Hyg; 1991 Nov; 45(5):539-47. PubMed ID: 1951863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of a Plasmodium vivax sporozoite vaccine.
    Gordon DM; Cosgriff TM; Schneider I; Wasserman GF; Majarian WR; Hollingdale MR; Chulay JD
    Am J Trop Med Hyg; 1990 Jun; 42(6):527-31. PubMed ID: 1695491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A.
    Fries LF; Gordon DM; Schneider I; Beier JC; Long GW; Gross M; Que JU; Cryz SJ; Sadoff JC
    Infect Immun; 1992 May; 60(5):1834-9. PubMed ID: 1563771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malaria vaccine research].
    Sellioğlu B
    Mikrobiyol Bul; 1986 Jan; 20(1):37-41. PubMed ID: 3523172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications.
    Hoffman SL; Oster CN; Plowe CV; Woollett GR; Beier JC; Chulay JD; Wirtz RA; Hollingdale MR; Mugambi M
    Science; 1987 Aug; 237(4815):639-42. PubMed ID: 3299709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of antibodies to sporozoites in Plasmodium falciparum malaria and correlation with protection.
    Webster HK; Brown AE; Chuenchitra C; Permpanich B; Pipithkul J
    J Clin Microbiol; 1988 May; 26(5):923-7. PubMed ID: 2454941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium falciparum: administration of anti-sporozoite antibodies during sporogony results in production of sporozoites which are not neutralized by human anti-circumsporozoite protein vaccine sera.
    do Rosario VE; Appiah A; Vaughan JA; Hollingdale MR
    Trans R Soc Trop Med Hyg; 1989; 83(3):305-7. PubMed ID: 2694460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells.
    Herrington DA; Losonsky GA; Smith G; Volvovitz F; Cochran M; Jackson K; Hoffman SL; Gordon DM; Levine MM; Edelman R
    Vaccine; 1992; 10(12):841-6. PubMed ID: 1455910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites.
    Herrington DA; Clyde DF; Losonsky G; Cortesia M; Murphy JR; Davis J; Baqar S; Felix AM; Heimer EP; Gillessen D
    Nature; 1987 Jul 16-22; 328(6127):257-9. PubMed ID: 2439920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites.
    Herrington DA; Clyde DF; Davis JR; Baqar S; Murphy JR; Cortese JF; Bank RS; Nardin E; DiJohn D; Nussenzweig RS
    Bull World Health Organ; 1990; 68 Suppl(Suppl):33-7. PubMed ID: 2094588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum: elicitation by peptides and recombinant circumsporozoite proteins of circulating mouse antibodies inhibiting sporozoite invasion of hepatoma cells.
    Hollingdale MR; Ballou WR; Aley SB; Young JF; Pancake S; Miller LH; Hockmeyer WT
    Exp Parasitol; 1987 Jun; 63(3):345-51. PubMed ID: 2438152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum.
    Ballou WR; Rothbard J; Wirtz RA; Gordon DM; Williams JS; Gore RW; Schneider I; Hollingdale MR; Beaudoin RL; Maloy WL
    Science; 1985 May; 228(4702):996-9. PubMed ID: 2988126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant.
    Hoffman SL; Edelman R; Bryan JP; Schneider I; Davis J; Sedegah M; Gordon D; Church P; Gross M; Silverman C
    Am J Trop Med Hyg; 1994 Nov; 51(5):603-12. PubMed ID: 7985753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of a Plasmodium falciparum sporozoite vaccine: boosting of antibody response in a population with prior natural exposure to malaria.
    Sherwood JA; Oster CN; Adoyo-Adoyo M; Beier JC; Gachihi GS; Nyakundi PM; Ballou WR; Brandling-Bennett AD; Schwartz IK; Were JB
    Trans R Soc Trop Med Hyg; 1991; 85(3):336-40. PubMed ID: 1949134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.